DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fresolimumab
Fresolimumab
In Vivo Imaging of Tgfβ Signalling Components Using Positron
Biological Therapy in Systemic Sclerosis
Treatment of Diffuse Cutaneous Systemic Sclerosis with Hyperimmune Caprine Serum
Clinical Research Newsletter for Colleagues in the Community
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
Recommended INN: List 63
Fresolimumab Suppl Methods
Epithelial–Mesenchymal Transition in Crohn's Disease
Targeting TGF-Β Signaling for Therapeutic Gain
Is There a Role for Radiation Therapy and Immunotherapy?
NCT# NCT02538471 WCM IRB # 1505016222 Title: LY2157299
13-400 Phrma Stateclinicaltrials MN 120913.Indd
Transforming Growth Factor-β in Stem Cells and Tissue Homeostasis
Plasmacytoid Dendritic Cells and CXCL4: Key Drivers of Systemic Sclerosis
Prescrire's Response
Identification of Key Genes and Pathways in Scleral Extracellular
Stembook 2018.Pdf
(INN) for Biological and Biotechnological Substances
Top View
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Inhibiting the Tgfβ Signaling Pathway Enhances Immune Checkpoint Blockade
Variants De La Portion Fc Des Igg Cartographie Et Analyse Brevets, Confrontation Aux Biomédicaments En Développement Et Proposition D’Une Nouvelle Nomenclature
Focal Irradiation and Systemic Tgfβ Blockade in Metastatic Breast Cancer
VIEW Open Access Recent Advances in the Treatment of Skin Involvement in Systemic Sclerosis Yoshihide Asano
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
TGF-B Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
IPF Model -SMC’S CRO Services
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
Identifying Major Immune Subsets of GI Tumors for Clinical
TGF-Β Antibody Uptake in Recurrent High Grade Glioma Imaged with 89Zr-Fresolimumab
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Complexities of TGF-Β Targeted Cancer Therapy Erin C
Recent Advances in the Development of TGF-Β Signaling Inhibitors for Anticancer Therapy
Comprehensive
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Therapeutic Implications of Tgfβ in Cancer Treatment: a Systematic Review
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer Eric C